Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches

The current standard of care for metastatic urothelial carcinoma is cisplatin-based chemotherapy but treatment is generally not curative. Mechanisms of resistance to conventional cytotoxic regimens include tumor cell drug efflux pumps, intracellular anti-oxidants, and enhanced anti-apoptotic signali...

Descripción completa

Detalles Bibliográficos
Autores principales: Bambury, Richard M., Rosenberg, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565214/
https://www.ncbi.nlm.nih.gov/pubmed/23390417
http://dx.doi.org/10.3389/fphar.2013.00003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565214/
https://www.ncbi.nlm.nih.gov/pubmed/23390417
http://dx.doi.org/10.3389/fphar.2013.00003

Ejemplares similares